Core Wealth Advisors (Florida)’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-200
Closed -$9.7K – 227
2024
Q1
$9.7K Hold
200
– – ﹤0.01% 192
2023
Q4
$10.7K Hold
200
– – ﹤0.01% 180
2023
Q3
$11.7K Hold
200
– – ﹤0.01% 144
2023
Q2
$12.6K Hold
200
– – 0.01% 140
2023
Q1
$12.6K Hold
200
– – 0.01% 138
2022
Q4
$10.6K Hold
200
– – ﹤0.01% 152
2022
Q3
$11K Hold
200
– – 0.01% 136
2022
Q2
$14K Hold
200
– – 0.01% 127
2022
Q1
$16K Hold
200
– – 0.01% 130
2021
Q4
$20K Hold
200
– – 0.01% 129
2021
Q3
$18K Hold
200
– – 0.01% 116
2021
Q2
$20K Hold
200
– – 0.01% 106
2021
Q1
$20K Hold
200
– – 0.02% 97
2020
Q4
$15K Hold
200
– – 0.01% 105
2020
Q3
$15K Hold
200
– – 0.01% 90
2020
Q2
$15K Hold
200
– – 0.01% 84
2020
Q1
$12K Hold
200
– – 0.01% 85
2019
Q4
$16K Buy
+200
New +$14.7K 0.01% 81

Other funds holding USNA

Core Wealth Advisors (Florida)'s USNA Position: Q2 2024 in Review

Core Wealth Advisors (Florida) sold out of Usana Health Sciences (USNA) in Q2 2024, closing a stake of 200 shares — an estimated $9.7K sold.

Core Wealth Advisors (Florida) first reported a position in USNA in Q4 2019 and held it in 18 quarters. The position peaked at $20K in Q4 2021. 154 funds tracked by Wall St. Rank hold USNA as of Q2 2024.

  • Core Wealth Advisors (Florida) reported no remaining Usana Health Sciences position as of Q2 2024 after selling out during the quarter.
  • Core Wealth Advisors (Florida) sold 200 Usana Health Sciences shares in Q2 2024, an estimated $9.7K.
  • Core Wealth Advisors (Florida) first reported a position in Usana Health Sciences in Q4 2019 and held it in 18 quarters.
  • Core Wealth Advisors (Florida)'s Usana Health Sciences position peaked at $20K in Q4 2021.
  • 154 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2024.

Based on Core Wealth Advisors (Florida)'s 13F filing for Q2 2024, filed 15 Aug 2024.